Sitemap

June 08, 2004 Articles

Filter by Available Specialty
  1. Diquafosol enters phase 3 trials
  2. Kyorin will market some Allergan glaucoma products in Japan
  3. Once-daily timolol granted U.S. marketing approval
  4. Surgeon: SLT as effective as medications in POAG, ocular hypertension